Cancer survivorship research: Opportunities and future needs for expanding the research base

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 7, 2008, Pages 1551-1557

  Bhatia, Smita ^b   Robison, Leslie L ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; AROMATASE INHIBITOR; BLEOMYCIN; CARMUSTINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DNA TOPOISOMERASE INHIBITOR; PLATINUM COMPLEX; PLATINUM DERIVATIVE; TAMOXIFEN; TAXANE DERIVATIVE; TRASTUZUMAB; VINCA ALKALOID;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; AVASCULAR NECROSIS; BLADDER CANCER; BLOOD CLOTTING DISORDER; BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CATARACT; CLINICAL TRIAL; COLORECTAL CANCER; CONGESTIVE HEART FAILURE; DISEASE FREE SURVIVAL; EARLY MENOPAUSE; EDITORIAL; ENDOCRINE DISEASE; GONAD FUNCTION; HEALTH STATUS; HEARING LOSS; HEART ARRHYTHMIA; HEMORRHAGIC CYSTITIS; HOT FLUSH; HUMAN; INFERTILITY; KIDNEY FUNCTION; LUNG DISEASE; LUNG FIBROSIS; MYELODYSPLASTIC SYNDROME; NEUROPATHY; OSTEOPOROSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION INJURY; SIDE EFFECT; STROKE; TREATMENT OUTCOME; UROGENITAL TRACT CANCER; UTERUS CANCER;

BIOMEDICAL RESEARCH; HUMANS; NEOPLASMS; SURVIVAL ANALYSIS; SURVIVAL RATE; UNITED STATES;

EID: 53549088629     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0490     Document Type: Editorial

References (56)

1. Hewitt M, Greenfield S, Stovall E. Cancer patient to cancer survivor: Lost in Transition. Washington DC, Committee on Cancer Survivorship: Improving Care and Quality of Life, National Cancer Policy Board, Institute of Medicine, and National Research Council, National Academies Press; 2006.
2. Anonymous. Cancer survivors: living longer, and now, better. Lancet 2004;364:2153-4.
3. Edwards BK, Howe HL, Ries LA, et al. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U S. cancer burden. Cancer 2002;94:2766-92.
4. Ayanian JZ, Jacobsen PB. Enhancing research on cancer survivors. J Clin Oncol 2006;24:5149-53.
5. Geenen MM, Cardous-Ubbink MC, Kremer LCM, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA 2007;297:2705-15.
6. Bhatia S, Robison LL. Late-effects among survivors of leukemia and lymphoma during childhood and adolescence. Br J Haematol 2003;122:345-9.
7. Oeffinger KC, Mertens AC, Sklar C, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006;355:1572-82.
8. Ganz PA. Monitoring the physical health of cancer survivors: a survivorship-focused medical history. J Clin Oncol 2006;24:5105-11.
9. Robison LL, Mertens AC, Boice JD, et al. Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Med Pediatr Oncol 2002;38:229-39.
10. Ayanian JZ, Chrischilles EA, Fletcher RH, et al. Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol 2004;22:2992-6.
11. Wagner EH, Greene SM, Hart G, et al. Building a research consortium of large health systems: The Cancer Research Network. J Natl Cancer Inst Monogr 2005;35:3-11.
12. Carver JR, Shapiro CL, Ng A, et al. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol 2007;25:3991-4008.
13. Landier W, Bhatia S, Eshelman DA, et al. Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-term Follow-up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol 2004;22:4979-90.
14. Neglia J, Friedman D, Yasui Y, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst 2001;93:618-29.
15. Kenney LB, Yasui YY, Inskip PD, et al. Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Intern Med 2004;141:590-7.
16. Curtis RE, Freedman DM, Ron E, et al. New malignancies among cancer survivors: SEER cancer registries, 1973-2000. Bethesda (MD): National Cancer Institute; 2006.
17. Ronckers CM, Sigurdson AJ, Stovall E, et al. Thyroid cancer in childhood cancer survivors: a detailed evaluation of radiation dose response and its modifiers. Radiat Res 2006;166:618-28.
18. Mertens AC, Mitby PA, Radloff G, et al. XRCC1 and glutathione-S- transferase gene polymorphisms and susceptibility to radiotherapy-related malignancies in survivors of Hodgkin disease. Cancer 2004;101:1463-72.
19. Smith RE, Bryant J, DeCellis A, et al. Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience. J Clin Oncol 2003;21:1195-204.
20. Hershman D, Neugut AI, Jacobson JS, et al. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. J Natl Cancer Inst 2007;99:196-205.
21. Blanco JG, Leisenring W, Davies SM, et al. Genetic polymorphisms in CBR3 and NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer. Cancer 2008;12:2789-95.
22. Mertens A, Yasui Y, Liu Y, et al. Pulmonary complications in survivors of childhood and adolescent cancer. a report from the Childhood Cancer Survivor Study. Cancer 2002;95:2431-41.
23. Bowers DC, Liu Y, Leisenring W, et al. Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2006;24:5277-82.
24. Bonneterre J, Roche H, Kerbrat P, et al. Long-term cardiac follow-up in relapse-free patients after six courses of fluorocil, epirubicin, and cyclophosphamide with either 50 or 100 mg of epirubicin, as adjuvant therapy for node positive breast cancer. French adjuvant study group. J Clin Oncol 2004;22:3070-9.
25. Brusamolino E, Baio A, Orlandi E, et al. Long-term events in adult patients with clinical stage IA-IIA non-bulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single institution 15-year follow-up. Clin Cancer Res 2006;12:6487-93.
26. Hequet O, Le OH, Moullet I, et al. Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults. J Clin Oncol 2004;22:1864-71.
27. Shapiro CL, Hardenbergh PH, Gelman R, et al. Cardiac effects of adjuvant doxorubicin and radiaion therapy in breast cancer patients. J Clin Oncol 1998;16:3493-501.
28. Sampath S, Schultheiss TE, Wong J. Dose response and factors related to interstitial pneumonitis after bone marrow transplant. Int J Radiat Oncol Biol Phys 2005;63:876-84.
29. Doyle JJ, Neugut AI, Jacobson JS, et al. Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study. J Clin Oncol 2005;23:8597-605.
30. Woodward WA, Giordano SH, Duan Z, et al. Supraclavicular radiation for breast cancer does not increase the 10-year risk of stroke. Cancer 2006;106:2556-62.
31. Mitby PA, Robison LL, Whitton JA, et al. Utilization of special education services and educational attainment among long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer 2003;97:1115-26.
32. Satariano WA, DeLorenze GN. The likelihood of returning to work after beast cancer. Public Health Rep 1996;111:236-41.
33. Tannock IF, Ahles TA, Ganz PA, et al. Cognitive impairment associated with chemotherapy for cancer: Report of a workshop. J Clin Oncol 2004;22:2233-9.
34. Sklar C, Whitton JA, Mertens AC, et al. Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2000;85:3227-32.
35. Sklar C, Mertens AC, Mitby PA, et al. Premature menopause in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 2006;98:890-6.
36. Leining MG, Gelber S, Rosenberg R, et al. Menopausal-type symptoms in young breast cancer survivors. Ann Oncol 2006;17:1777-82.
37. Herman D, Ganz PA, Petersen L, et al. Obesity and cardiovascular risk factors in younger breast cancer survivors: The Cancer and Menopause Study. Breast Cancer Res Treat 2005;93:13-23.
38. Green DM, Whitton JA, Stovall E, et al. Pregnancy outcome of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Am J Obst Gynecol 2002;1887:1070-80.
39. Green DM, Whitton JA, Stovall E, et al. Pregnancy outcome of partners of male survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2003;21:716-21.
40. Ganz PA, Greendale GA, Petersen L, et al. Breast cancer in younger women: repoductive and late health effects of treatment. J Clin Oncol 2003;21:4184-93.
41. Hudson MM, Mertens AC, Yasuai YY, et al. Health status of adults who are long-term childhood cancer survivors: a report from the Childhood Cancer Survivor Study. JAMA 2003;290:1583-92.
42. Ganz PA, Moinpour CM, Pauler DK, et al. Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133. J Clin Oncol 2003;21:3512-9.
43. Kadan-Lottick NS, Robison LL, Gurney JG, et al. What do childhood cancer survivors know about their past diagnosis and treatment? JAMA 2002;287:1832-9.
44. Yeazel MW, Oeffinger KC, Gurney JG, et al. The cancer screening practices of adult survivors of childhood cancer. Cancer 2004;100:631-40.
45. Zebrack B, Gurney J, Oeffinger K, et al. Psychological outcomes in long-term survivors of childhood brain cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2004;22:999-1006.
46. Zebrack BJ, Zeltzer LK, Whitton JA, et al. Psychological outcomes in long-term survivors of childhood leukemia, Hodgkin's disease and non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Pediatrics 2002;110:42-52.
47. Mandelblatt J, Armetta C, Yabroff KR, et al. Descriptive review of the literature on breast cancer outcomes: 1990 through 2000. J Natl Cancer Inst Monogr 2004;33:8-44.
48. Ganz PA, Kwan L, Stanton AL, et al. Quality of life at the end of primary treatment of breast cancer: first results from the Moving Beyond Cancer randomized trial. J Natl Cancer Inst 2004;96:376-87.
49. Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008;358:1250-61.
50. Oeffinger KC, Mertens AC, Hudson MM, et al. Healthcare of young adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Family Med 2004;2:61-70.
51. Earle CC, Neville BA. Under use of necessary care among cancer survivors. Cancer 2004;101:1712-9.
52. Yabroff KR, Lawence W, Clauser S, et al. Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst 2004;96:1322-30.
53. Mertens AC, Yasui YY, Neglia JP, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol 2001;19:3163-72.
54. Bhatia S, Francisco L, Baker KS, et al. Late mortality in two-year survivors of autologous hematopoietic cell transplantation (HCT): report from the BMT Survivor Study (BMTSS). Blood 2005;105:4215-22.
55. Bhatia S, Francisco L, Carter A, et al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood 2007;110:3784-92.
56. Emmons K, Li FP, Whitton JA, et al. Predictors of smoking initiation and cessation among childhood cancer survivors: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2002;20:1608-16.